ALNY Alnylam Pharmaceuticals RESULTS: Q2, Q2 ADJ Net Income $251.801M, Q2 Operating Income $231.441M, Q2 ADJ Operating Income $318.066M, Q2
ALNY Alnylam Pharmaceuticals RESULTS: Q2, Q2 ADJ Net Income $251.801M, Q2 Operating Income $231.441M, Q2 ADJ Operating Income $318.066M, Q2 ADJ EPS $1.84 vs. EST $1.55, Q2 Net Income $164.494M, Q2 REV $1,290.948M vs. EST $1.323B
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.